All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-WFY1626 | Anti-TCF12 (CBFYH-2786) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Human | CBFYH-2786 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY1627 | Anti-TCF12 (CBFYH-2787) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-2787 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY1628 | Anti-TCF12 (CBFYH-2788) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-2788 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY4879 | Anti-TCF12 (CBFYH-2786) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Human | CBFYH-2786 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY4880 | Anti-TCF12 (CBFYH-2787) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-2787 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY4881 | Anti-TCF12 (CBFYH-2788) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYH-2788 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ230 | Anti-TCF12 (2E9) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 2E9 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ231 | Anti-TCF12 (4D6) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 4D6 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ730 | Anti-TCF12 (2E9) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 2E9 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ731 | Anti-TCF12 (4D6) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 4D6 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION